A Phase 1 Study of the Safety of AAV8-LSPhGAA (ACTUS-101) in Late-onset Pompe Disease (LOPD)- Cohort II

Administered By

Awarded By

Contributors

Start/End

  • July 8, 2019 - September 30, 2023